Differentiation state and responses to hematopoietic growth factors of murine myeloid cells transformed by myb
- PMID: 8219231
Differentiation state and responses to hematopoietic growth factors of murine myeloid cells transformed by myb
Abstract
Murine hematopoietic cells can be transformed in vitro by recombinant retroviruses that express the myb oncogene, and hematopoietic growth factor (HGF)-dependent myeloid cell lines can be derived from these transformed primary cells. In this study, the differentiation state and responses of myb-transformed hematopoietic cells (MTHCs) have been investigated. We find that MTHCs exhibit properties of early myeloid progenitors including synergistic responses to combinations of HGFs and expression of certain surface markers. As reported previously, MTHCs respond well to granulocyte-macrophage colony-stimulating factor (GM-CSF) but can also respond to interleukin-3 (IL-3); the response to the latter factor depends on the mouse strain from which the cells are derived. Although these single factors stimulate MTHCs, combinations of these factors with colony-stimulating factor-1 (CSF-1 or M-CSF) or Steel factor (SLF or SCF) act synergistically to promote colony formation. The surface markers expressed by MTHCs include both granulocyte-macrophage lineage specific antigens Gr-1, 7/4, F4/80, and Mac-1, as well as two antigens found on early progenitors and stem cells--Thy-1 and Sca-1 (Ly6E). Expression of the latter markers is often heterogeneous and can be modulated by the growth factors to which the cells are exposed. Finally, we show that monocytic differentiation of MTHCs can be induced by exposure to tumor necrosis factor (TNF alpha). Taken together, these results suggest that MTHCs will be a useful model for studying HGF/cytokine responses in both proliferation and differentiation.
Similar articles
-
Murine myeloid cells transformed by myb require fibroblast-derived or autocrine growth factors in addition to granulocyte-macrophage colony-stimulating factor for proliferation.Blood. 1994 Jan 1;83(1):209-16. Blood. 1994. PMID: 7506080
-
Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit.Blood. 1996 Aug 1;88(3):863-9. Blood. 1996. PMID: 8704242
-
In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.Immunol Lett. 2004 Feb 15;91(2-3):221-7. doi: 10.1016/j.imlet.2003.12.008. Immunol Lett. 2004. PMID: 15019293
-
Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review.
-
The effect of c-raf antisense oligonucleotides on growth factor-induced proliferation of hematopoietic cells.Curr Top Microbiol Immunol. 1996;211:43-53. doi: 10.1007/978-3-642-85232-9_5. Curr Top Microbiol Immunol. 1996. PMID: 8585963 Review.
Cited by
-
TNF-α promotes IFN-γ-induced CD40 expression and antigen process in Myb-transformed hematological cells.ScientificWorldJournal. 2012;2012:621969. doi: 10.1100/2012/621969. Epub 2012 Apr 1. ScientificWorldJournal. 2012. PMID: 22547990 Free PMC article.
-
Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.Elife. 2021 Feb 2;10:e65905. doi: 10.7554/eLife.65905. Elife. 2021. PMID: 33527899 Free PMC article.
-
Winner of the Theodore E. Woodward Award: c-Myb and the coordinate regulation of thymic genes.Trans Am Clin Climatol Assoc. 1996;107:115-24. Trans Am Clin Climatol Assoc. 1996. PMID: 8725565 Free PMC article. Review. No abstract available.
-
MYB suppresses differentiation and apoptosis of human breast cancer cells.Breast Cancer Res. 2010;12(4):R55. doi: 10.1186/bcr2614. Epub 2010 Jul 26. Breast Cancer Res. 2010. PMID: 20659323 Free PMC article.
-
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells.Blood Cancer J. 2012 May;2(5):e71. doi: 10.1038/bcj.2012.16. Epub 2012 May 11. Blood Cancer J. 2012. PMID: 22829973 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
